SOW
SRPT icon

State of Wyoming’s Sarepta Therapeutics SRPT Stock Holding History

State of Wyoming’s Portfolio SRPT Stock Details SRPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-1,525
Closed -$33.2K – 2217
2026
Q1 		$33.2K Sell
1,525
-5,463
-78% -$106K ﹤0.01% 1612
2025
Q4 		$150K Buy
+6,988
New +$147K 0.02% 1136
2022
Q3 		– Sell
-11
Closed -$1K – 1910
2022
Q2 		$1K Buy
11
+3
+38% +$221 ﹤0.01% 1816
2022
Q1 		$1K Buy
+8
New +$613 ﹤0.01% 1746
2021
Q3 		– Sell
-5
Closed – – 1329
2021
Q2 		$0 Buy
+5
New +$379 ﹤0.01% 1219

Other funds holding SRPT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

State of Wyoming's SRPT Position: Q2 2026 in Review

State of Wyoming sold out of Sarepta Therapeutics (SRPT) in Q2 2026, closing a stake of 1,525 shares — an estimated $33.2K sold.

State of Wyoming first reported a position in SRPT in Q2 2021 and held it in 5 quarters. The position peaked at $150K in Q4 2025. 323 funds tracked by Wall St. Rank hold SRPT as of Q2 2026.

  • State of Wyoming reported no remaining Sarepta Therapeutics position as of Q2 2026 after selling out during the quarter.
  • State of Wyoming sold 1,525 Sarepta Therapeutics shares in Q2 2026, an estimated $33.2K.
  • State of Wyoming first reported a position in Sarepta Therapeutics in Q2 2021 and held it in 5 quarters.
  • State of Wyoming's Sarepta Therapeutics position peaked at $150K in Q4 2025.
  • 323 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q2 2026.

Based on State of Wyoming's 13F filing for Q2 2026, filed 6 Aug 2026.